---
trial_id: 1888
discovery_date: 2022-10-01 16:58:48.386442
date: 2022-10-01 16:58:48.386442
title: "A Multicenter, Open-Label, Extension Study to Evaluate the Long Term Safety and Efficacy of BIIB019, Daclizumab High Yield Process (DAC HYP), Monotherapy in Subjects With Multiple Sclerosis Who Hav..."
summary: |
  <p>EudraCT Number: 2012-003176-39<br />Sponsor Protocol Number: 205MS303<br />Sponsor Name: Biogen Idec Research Limited<br />Start Date: 2013-05-31<br />Medical condition: Relapsing-remitting Multiple Sclerosis<br />Disease: <br />Version: 20.0<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10063399<br />Term: Relapsing-remitting multiple sclerosis<br />Level: PT<br /><br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/DE">DE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/IT">IT</a> (Prematurely Ended), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/CZ">CZ</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/HU">HU</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/PL">PL</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/SE">SE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/ES">ES</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/IE">IE</a> (Prematurely Ended), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/GB">GB</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/FI">FI</a> (Prematurely Ended), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/GR">GR</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/FR">FR</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/DK">DK</a> (Completed)</p>
link: 'https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-003176-39'
published_date: NaT
trial_source: 
relevant: 
options:
  unlisted: false
---
<p>EudraCT Number: 2012-003176-39<br />Sponsor Protocol Number: 205MS303<br />Sponsor Name: Biogen Idec Research Limited<br />Start Date: 2013-05-31<br />Medical condition: Relapsing-remitting Multiple Sclerosis<br />Disease: <br />Version: 20.0<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10063399<br />Term: Relapsing-remitting multiple sclerosis<br />Level: PT<br /><br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/DE">DE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/IT">IT</a> (Prematurely Ended), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/CZ">CZ</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/HU">HU</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/PL">PL</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/SE">SE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/ES">ES</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/IE">IE</a> (Prematurely Ended), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/GB">GB</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/FI">FI</a> (Prematurely Ended), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/GR">GR</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/FR">FR</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/DK">DK</a> (Completed)</p>